GoHealth Inc. (GOCO) Stock Falls on Q4 2025 Earnings

By: Quiver EarningsTracker

Posted: 1 day, 18 hours ago / March 31, 2026 8:47 p.m. UTC

GOCO

GoHealth Inc. (GOCO) reported fourth-quarter 2025 results marked by a steep revenue decline and sizable losses.

Total revenue: $12.6 million (down 96.8% year‑over‑year).

Gross profit: $12.6 million (down 96.3% year‑over‑year).

Operating loss: -$32.3 million (worsened 147.3% year‑over‑year).

Net loss attributable to common shareholders: -$32.6 million (down 227.8% year‑over‑year).

Diluted earnings per share: -$1.03 per diluted share (declined 139.3% year‑over‑year).

Liquidity and cash flow highlights:

Cash from operating activities: -$39.1 million (down 367.6% year‑over‑year).

Purchases of property, plant and equipment: $0 (100.0% year‑over‑year decline).

Cash and cash equivalents: $32.9 million (down 19.6% year‑over‑year).

Total liabilities: $992.7 million (down 3.6% year‑over‑year).

Additional income-statement context and market reaction:

Cost of sales: $20.1 million (down 61.5% year‑over‑year).

The quarter reflects severe top-line pressure alongside elevated losses and negative operating cash flow.

Shares moved following the release, with a reported change of -2.7% since market close.

Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.

GoHealth Inc. Hedge Fund Activity

We have seen 32 institutional investors add shares of GoHealth Inc. stock to their portfolio, and 25 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

BLACKROCK, INC. added 64,318 shares (+20.2%) to their portfolio in Q4 2025, for an estimated $138,283
FOCUS PARTNERS WEALTH removed 56,082 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $120,576
VANGUARD GROUP INC added 55,946 shares (+24.3%) to their portfolio in Q4 2025, for an estimated $120,283
MARSHALL WACE, LLP removed 48,882 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $235,611
RENAISSANCE TECHNOLOGIES LLC removed 48,778 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $104,872
GLENDON CAPITAL MANAGEMENT LP removed 42,745 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $91,901
UBS GROUP AG added 42,163 shares (+1237.2%) to their portfolio in Q4 2025, for an estimated $90,650

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.